Population
Patients with vasovagal syncope
Design
Review
Authors
Loading...
Offers no immediate therapeutic targets for vasovagal syncope; leaves open identification of active vasodilatory mechanisms.
The exact neural pathways and mechanisms causing active skeletal muscle vasodilation during vasovagal syncope remain unidentified.
Dietz et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: